Key Financial Data Of Group

Noile-Immune Biotech Inc. - Filing #7338555

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
2023-01-01 to
2023-03-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-339,567,000 JPY
-1,127,594,000 JPY
-493,787,000 JPY
Net assets
5,349,775,000 JPY
5,687,452,000 JPY
3,806,221,000 JPY
Total assets
5,456,992,000 JPY
5,778,946,000 JPY
4,008,290,000 JPY
Basic earnings (loss) per share
-7.86
-27.25
-12.49
Diluted earnings per share
Equity-to-asset ratio
0.979 xbrli:pure
0.983 xbrli:pure
0.948 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.